简介：
Overview
This article presents a protocol for the in vitro selection of engineered transcriptional repressors (ETRs) that achieve high, long-term, stable on-target silencing with minimal off-target effects. The described workflow streamlines the selection process, enabling researchers to focus on the most promising ETR candidates for therapeutic applications.
Key Study Components
Area of Science
- Gene silencing technologies
- Epigenetic regulation
- CRISPR/Cas9 applications
Background
- Gene knock-down methods include RNA interference and artificial nucleases.
- Epigenetic silencing utilizes engineered transcriptional repressors to modify chromatin and inhibit gene expression.
- Long-term inheritance of transcriptional repression is a key advantage of this technology.
- Identifying suitable cell lines for gene silencing is critical for effective experimentation.
Purpose of Study
- To develop a reliable method for selecting ETRs with optimal silencing efficiency.
- To minimize off-target effects in gene regulation.
- To facilitate the application of ETRs in therapeutic contexts.
Methods Used
- Identification of target genes using The Human Protein Atlas.
- Design and delivery of gRNAs and ETRs using CRISPR/Cas9 technology.
- Flow cytometry for monitoring gene expression and silencing efficiency.
- Screening and validation of ETRs through molecular cloning techniques.
Main Results
- Successful integration of a tdTomato fluorescent reporter into the B2M gene.
- Identification of gRNAs with high on-target efficiency and low off-target activity.
- Demonstration of long-term silencing in selected cell lines.
- Establishment of a robust workflow for ETR selection and evaluation.
Conclusions
- The developed protocol enhances the selection process for effective ETRs.
- Long-term gene silencing can be achieved with minimal off-target effects.
- This approach holds promise for therapeutic applications in gene regulation.
What are engineered transcriptional repressors?
Engineered transcriptional repressors (ETRs) are proteins designed to bind to specific DNA sequences and induce epigenetic modifications that inhibit gene expression.
How does the protocol improve gene silencing?
The protocol streamlines the selection of ETRs, focusing on candidates with high silencing efficiency and low off-target effects, enhancing overall effectiveness.
What is the significance of using CRISPR/Cas9 in this study?
CRISPR/Cas9 technology allows for precise editing of the genome, facilitating the integration of ETRs and the monitoring of gene expression changes.
How are cell lines selected for the experiments?
Cell lines are selected based on their expression of the target gene and the availability of efficient gene delivery protocols.
What role does flow cytometry play in this research?
Flow cytometry is used to measure the expression levels of fluorescent reporters, allowing for the assessment of silencing efficiency over time.
Can the results be applied to therapeutic settings?
Yes, the findings provide a foundation for developing ETRs that can be used in therapeutic applications for gene regulation.
繁體中文
